Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05840510
Title Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44121 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030-4000 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field